Global diagnostic imaging market to reach $31.9 billion in 2023: GlobalData
Diagnostic imaging will become an increasingly vital process in healthcare
Diagnostic imaging will become an increasingly vital process in healthcare
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
The company has played an important role in the procurement and distribution of emergency medical supplies supporting the Union Health Ministry for Covid–19 pandemic management
Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Allam was serving recently as the CEO at Public Investment Fund
This partnership stemmed from a successful customer-supplier relationship spanning several years.
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
Subscribe To Our Newsletter & Stay Updated